General
Preferred name
PIOGLITAZONE HYDROCHLORIDE
Synonyms
U-72107E ()
Pioglitazone (hydrochloride) ()
U 72107A ()
AD 4833 ()
Pioglitazone HCl ()
AD-4833, U-72107E ()
Actos ()
Pioglitazone (as hydrochloride) ()
Piomed ()
Diabiom ()
Glizofar ()
NSC-758876 ()
Glidipion ()
STR-001 ()
U-72107A ()
P&D ID
PD001166
CAS
111025-46-8
112529-15-4
Tags
natural product
drug
available
Drug Status
approved
Max Phase
Phase 4
Drug indication
Antidiabetic
First approval
1999
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Selective PPARgamma agonist; antidiabetic agent
(Tocriscreen Plus)
DESCRIPTION
Selective, high affinity PPARalpha agonist
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
24
Properties
(calculated by RDKit )
Molecular Weight
392.1
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
3
Aromatic Ring Count
2
cLogP
3.58
TPSA
68.29
Fraction CSP3
0.32
Chiral centers
1.0
Largest ring
6.0
QED
0.78
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Nuclear Receptors
Primary Target
PPAR?
MOA
Agonist
Target
PPAR? agonist
Ferroptosis
PPAR
Ferroptosis,P450 (e.g. CYP17),PPAR
Pathway
Apoptosis
Cell Cycle/DNA Damage
Vitamin D Related/Nuclear Receptor
Source data